Wilson Sonsini Goodrich & Rosati advised Tenaya Therapeutics on the transaction, and Davis Polk & Wardwell advised the underwriters. Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Edgewise Therapeutics on the transaction, and Cooley represented the underwriters. Edgewise Therapeutics, Inc. (“Edgewise”) (NASDAQ: EWTX) announced the pricing of an underwritten...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Alpine Immune Sciences on the offering, and Latham & Watkins advised the underwriters. Alpine Immune Sciences, Inc. (Nasdaq: ALPN) announced the...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Denodo on the transaction. Denodo announced that they have signed a definitive agreement for TPG Growth (NASDAQ:TPG), the firm’s middle...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati is representing Pacific Biosciences, and Fenwick & West is representing Apton Biosystems in the transaction. 8Pacific Biosciences of California (NASDAQ: PACB) (PacBio) announced...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised IGM Biosciences, Inc. on the transaction. IGM Biosciences, Inc. (IGM) announced the closing of its previously announced upsized underwritten public offering...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised PacBio in the offering. Pacific Biosciences of California, Inc. (PacBio) (NASDAQ: PACB) announced that it has entered into a privately negotiated...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Pacific Biosciences of California on the offering, and Davis Polk advised the representatives of the several underwriters involved. Pacific Biosciences of California Inc. announced...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Flexe on the deal. Flexe, the programmatic logistics leader, announced a $119 million Series D financing round at a $1...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised IGM on the transaction. IGM Biosciences, Inc. announced the pricing of its underwritten public offering of 8,695,653 shares of its...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Udemy on the deal, while Simpson Thacher represented the underwriters. Udemy announced the pricing of its initial public offering of...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Exodus Movement, Inc. on the deal. Exodus Movement, Inc., the developer of the Exodus Wallet, a leading non-custodial cryptocurrency software...
You must be a Standard 1 Year member to access this content.
